BioHealth Innovation, Inc. — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Palleon Pharmaceuticalspalleonpharma.comin𝕏Series A · Oct 2017 · $48M
Palleon Pharma develops small molecule and biologic drugs targeting autoimmune and inflammatory diseases using proprietary glycoscience platforms.
BiotechDigital HealthMedical DevicesWaltham, US
Jim Broderick(Co-Founder)inJohn Hennessy(Executive Officer)Karen Hong(Director)James Lee(Director)Stephen Hoffman(Director)Li Peng(Chief Scientific Officer)
Co-investorsMatrix Capital ManagementPfizer VenturesPfizer Venture InvestmentsSR One Capital ManagementTakeda VenturesVertex Ventures HC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


